Crawford Investment Counsel’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.8M Sell
148,066
-4,603
-3% -$531K 0.3% 79
2025
Q4
$16.1M Sell
152,669
-9,467
-6% -$889K 0.27% 83
2025
Q3
$13.6M Sell
162,136
-40,074
-20% -$3.3M 0.23% 92
2025
Q2
$16M Sell
202,210
-68,495
-25% -$5.44M 0.28% 84
2025
Q1
$24.3M Sell
270,705
-565,840
-68% -$52.8M 0.43% 58
2024
Q4
$83.2M Buy
836,545
+20,382
+2% +$2.1M 1.5% 23
2024
Q3
$92.7M Buy
816,163
+11,515
+1% +$1.37M 1.58% 22
2024
Q2
$99.6M Sell
804,648
-7,081
-0.9% -$912K 1.9% 12
2024
Q1
$107M Sell
811,729
-12,115
-1% -$1.49M 2% 9
2023
Q4
$89.8M Sell
823,844
-27,345
-3% -$2.84M 1.8% 17
2023
Q3
$87.6M Sell
851,189
-9,914
-1% -$1.07M 1.9% 15
2023
Q2
$99.4M Sell
861,103
-9,916
-1% -$1.13M 2.02% 14
2023
Q1
$92.7M Sell
871,019
-181,987
-17% -$19.6M 1.98% 12
2022
Q4
$117M Sell
1,053,006
-140,303
-12% -$14.3M 2.51% 6
2022
Q3
$103M Buy
1,193,309
+702
+0.1% +$62.7K 2.43% 6
2022
Q2
$109M Buy
1,192,607
+2,864
+0.2% +$254K 2.4% 6
2022
Q1
$97.6M Sell
1,189,743
-125,430
-10% -$9.89M 1.89% 14
2021
Q4
$101M Sell
1,315,173
-24,792
-2% -$1.97M 1.91% 12
2021
Q3
$101M Buy
1,339,965
+31,136
+2% +$2.37M 2.06% 10
2021
Q2
$102M Buy
1,308,829
+216,084
+20% +$16.1M 2.06% 11
2021
Q1
$80.4M Buy
1,092,745
+62,589
+6% +$4.62M 1.81% 18
2020
Q4
$80.4M Buy
1,030,156
+10,385
+1% +$794K 1.99% 14
2020
Q3
$80.7M Buy
1,019,771
+9,820
+1% +$769K 2.2% 11
2020
Q2
$74.5M Buy
1,009,951
+7,110
+0.7% +$535K 2.14% 13
2020
Q1
$73.6M Sell
1,002,841
-42,505
-4% -$3.34M 2.48% 10
2019
Q4
$90.7M Sell
1,045,346
-1,036
-0.1% -$85.1K 2.34% 5
2019
Q3
$84M Sell
1,046,382
-154,330
-13% -$12.4M 2.33% 7
2019
Q2
$96.1M Sell
1,200,712
-2,498
-0.2% -$191K 2.71% 4
2019
Q1
$95.5M Sell
1,203,210
-126,026
-9% -$9.43M 2.84% 2
2018
Q4
$96.9M Sell
1,329,236
-129,740
-9% -$9.16M 3.28% 2
2018
Q3
$98.8M Sell
1,458,976
-35,192
-2% -$2.24M 3.01% 2
2018
Q2
$86.5M Sell
1,494,168
-17,744
-1% -$1M 2.75% 3
2018
Q1
$78.6M Buy
1,511,912
+68,403
+5% +$3.69M 2.48% 4
2017
Q4
$77.5M Buy
1,443,509
+28,711
+2% +$1.59M 2.41% 8
2017
Q3
$86.4M Buy
1,414,798
+49,409
+4% +$3M 2.81% 3
2017
Q2
$83.5M Buy
1,365,389
+14,773
+1% +$899K 2.87% 2
2017
Q1
$81.9M Buy
1,350,616
+21,805
+2% +$1.32M 2.9% 2
2016
Q4
$74.6M Sell
1,328,811
-27,682
-2% -$1.62M 2.71% 5
2016
Q3
$80.8M Buy
1,356,493
+102,228
+8% +$5.98M 2.96% 2
2016
Q2
$68.9M Buy
1,254,265
+31,575
+3% +$1.68M 2.74% 5
2016
Q1
$61.7M Buy
1,222,690
+45,952
+4% +$2.25M 2.59% 9
2015
Q4
$59.3M Sell
1,176,738
-29,640
-2% -$1.49M 2.61% 8
2015
Q3
$56.9M Sell
1,206,378
-55,528
-4% -$2.95M 2.48% 10
2015
Q2
$68.5M Sell
1,261,906
-67,441
-5% -$3.78M 2.6% 8
2015
Q1
$72.9M Sell
1,329,347
-8,617
-0.6% -$488K 2.64% 9
2014
Q4
$72.5M Sell
1,337,964
-18,897
-1% -$1.05M 2.56% 18
2014
Q3
$76.8M Buy
1,356,861
+46,512
+4% +$2.61M 2.77% 8
2014
Q2
$72.3M Sell
1,310,349
-59,046
-4% -$3.22M 2.56% 14
2014
Q1
$74.2M Sell
1,369,395
-111,743
-8% -$5.79M 2.69% 11
2013
Q4
$70.7M Buy
1,481,138
+219
+0% +$10K 2.59% 15
2013
Q3
$67.3M Sell
1,480,919
-4,912
-0.3% -$224K 2.67% 14
2013
Q2
$65.9M Buy
+1,485,831
New +$66.4M 2.72% 10

Other funds holding MRK

Crawford Investment Counsel's MRK Position: Q1 2026 in Review

Crawford Investment Counsel reduced its Merck (MRK) stake by 3% in Q1 2026, selling an estimated $531K and leaving 148,066 shares worth $17.8M. The position accounts for 0.3% of the portfolio, ranked #79.

Crawford Investment Counsel first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $117M in Q4 2022. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Crawford Investment Counsel held 148,066 shares of Merck worth $17.8M as of Q1 2026.
  • Crawford Investment Counsel sold 4,603 Merck shares in Q1 2026, an estimated $531K.
  • Merck made up 0.3% of Crawford Investment Counsel's portfolio in Q1 2026, its #79 holding.
  • Crawford Investment Counsel first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Crawford Investment Counsel's Merck position peaked at $117M in Q4 2022.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Crawford Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.